Cargando…
Serum HDAC4 level in rheumatoid arthritis: Longitudinal change during treatment and correlation with clinical outcomes
OBJECTIVE: Histone deacetylase 4 (HDAC4) modulates immunity, inflammation, and osteoblast differentiation to engage in rheumatoid arthritis (RA) etiology. This study aimed to evaluate the HDAC4 longitudinal change and its relationship with clinical features and outcomes in RA patients. METHODS: Eigh...
Autores principales: | Mou, Xiaoyue, Jin, Yi, Jin, Du, Guan, Jintao, Zhang, Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396184/ https://www.ncbi.nlm.nih.gov/pubmed/35792020 http://dx.doi.org/10.1002/jcla.24594 |
Ejemplares similares
-
Changes of serum IgG glycosylation patterns in rheumatoid arthritis
por: Deng, Xiaoyue, et al.
Publicado: (2023) -
Ellagic Acid Alleviates Rheumatoid Arthritis in Rats through Inhibiting MTA1/HDAC1-Mediated Nur77 Deacetylation
por: Song, Huanjin, et al.
Publicado: (2021) -
Serum proteomic networks associate with pre-clinical rheumatoid arthritis autoantibodies and longitudinal outcomes
por: O’Neil, Liam J., et al.
Publicado: (2022) -
Serum catestatin levels in patients with rheumatoid arthritis
por: Simac, Petra, et al.
Publicado: (2022) -
Serum Adropin Levels in Patients with Rheumatoid Arthritis
por: Simac, Petra, et al.
Publicado: (2022)